Comparison of one-stage and chromogenic factor VIII assays to tailor the dose of recombinant factor VIII-Fc fusion protein (rFVIIIFc, efmoroctocog alfa) in adult patients with haemophilia A: Single-centre, real-world experience of surgery.

Stéphanie DésageChristophe NougierSandrine MeunierValérie ChamouardEmilie JousselmeYesim DargaudAnne Lienhart

Published in: Haemophilia : the official journal of the World Federation of Hemophilia (2023)

Dose adjustment of rFVIIIFc according to FVIII: C measured by CSA is effective, safe and well tolerated in patients with haemophilia A undergoing invasive surgery.

Keyphrases

minimally invasive
coronary artery bypass
surgical site infection
high throughput
replacement therapy
atrial fibrillation